AstraZeneca Pharma India gets CDSCO approval to import, sell cancer treatment medicine

AstraZeneca Pharma India has received approval from CDSCO to import and distribute the cancer treatment drug Durvalumab solutions. This approval allows the marketing of Durvalumab in combination with Tremelimumab for treating unresectable hepatocellular carcinoma in India, pending related statutory approvals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yMGYctk
via IFTTT